extensive-sclc-treatment.com - Immunotherapy for Unresectable HCC, Advanced BTC, Stage III or IV NSCLC, & ES-SCLC | For HCPs | IMFINZI® (durvalumab)

home > domains > extensive-sclc-treatment.com

Description: Learn more about IMFINZI® (durvalumab), an immunotherapy for adult patients with metastatic NSCLC, unresectable Stage III NSCLC, extensive-stage SCLC, advanced or metastatic BTC, & unresectable HCC.

Example domain paragraphs

Important Safety Information

Unresectable Stage III

Non-small Cell Lung Cancer